John Nosenzo - 02 Jun 2021 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role
Director
Signature
/s/ Megan Smeykal, Attorney-in-fact
Issuer symbol
TELA
Transactions as of
02 Jun 2021
Net transactions value
$0
Form type
4
Filing time
04 Jun 2021, 17:08:42 UTC
Next filing
14 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TELA Stock Option (Right to Buy) Award $0 +8,000 $0.000000 8,000 02 Jun 2021 Common Stock 8,000 $13.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 36 equal monthly installments on the second day of each of the 36 calendar months immediately following June 2, 2021, subject to the Reporting Person's continued service through the applicable vesting date.